大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/02/26 | 2,930 | 2,967 | 2,921 | 2,940 | -10 | -0.3% | 1,461,100 |
2013/02/25 | 2,994 | 2,997 | 2,950 | 2,950 | -29 | -1% | 1,640,100 |
2013/02/22 | 2,959 | 2,985 | 2,930 | 2,979 | +27 | +0.9% | 2,425,600 |
2013/02/21 | 2,969 | 2,975 | 2,941 | 2,952 | -11 | -0.4% | 1,024,500 |
2013/02/20 | 2,949 | 2,970 | 2,938 | 2,963 | +34 | +1.2% | 1,301,400 |
2013/02/19 | 2,928 | 2,958 | 2,925 | 2,929 | ±0 | ±0% | 1,228,700 |
2013/02/18 | 2,910 | 2,942 | 2,910 | 2,929 | +16 | +0.5% | 867,100 |
2013/02/15 | 2,964 | 2,964 | 2,904 | 2,913 | -52 | -1.8% | 1,403,100 |
2013/02/14 | 2,989 | 2,994 | 2,957 | 2,965 | +9 | +0.3% | 1,077,200 |
2013/02/13 | 2,961 | 3,000 | 2,934 | 2,956 | -10 | -0.3% | 1,358,500 |
2013/02/12 | 2,930 | 2,998 | 2,901 | 2,966 | +55 | +1.9% | 1,469,900 |
2013/02/08 | 2,939 | 2,962 | 2,896 | 2,911 | -59 | -2% | 1,478,900 |
2013/02/07 | 2,975 | 2,988 | 2,948 | 2,970 | -17 | -0.6% | 1,250,000 |
2013/02/06 | 2,948 | 2,999 | 2,938 | 2,987 | +65 | +2.2% | 1,101,700 |
2013/02/05 | 2,892 | 2,946 | 2,891 | 2,922 | +4 | +0.1% | 1,198,900 |
2013/02/04 | 2,935 | 2,939 | 2,908 | 2,918 | ±0 | ±0% | 816,800 |
2013/02/01 | 2,900 | 2,941 | 2,895 | 2,918 | -30 | -1% | 926,500 |
2013/01/31 | 2,953 | 2,968 | 2,918 | 2,948 | +17 | +0.6% | 1,466,100 |
2013/01/30 | 2,950 | 2,950 | 2,902 | 2,931 | -30 | -1% | 1,410,600 |
2013/01/29 | 2,868 | 3,005 | 2,859 | 2,961 | +137 | +4.9% | 2,963,600 |
2013/01/28 | 2,862 | 2,903 | 2,823 | 2,824 | -46 | -1.6% | 1,263,000 |
2013/01/25 | 2,788 | 2,877 | 2,783 | 2,870 | +96 | +3.5% | 1,867,800 |
2013/01/24 | 2,728 | 2,774 | 2,722 | 2,774 | +56 | +2.1% | 1,685,700 |
2013/01/23 | 2,681 | 2,745 | 2,669 | 2,718 | -2 | -0.1% | 1,278,100 |
2013/01/22 | 2,712 | 2,737 | 2,693 | 2,720 | +4 | +0.1% | 982,700 |
2013/01/21 | 2,713 | 2,747 | 2,709 | 2,716 | -33 | -1.2% | 833,600 |
2013/01/18 | 2,712 | 2,756 | 2,700 | 2,749 | +49 | +1.8% | 1,299,500 |
2013/01/17 | 2,695 | 2,715 | 2,676 | 2,700 | +5 | +0.2% | 2,094,600 |
2013/01/16 | 2,640 | 2,708 | 2,635 | 2,695 | -13 | -0.5% | 2,126,800 |
2013/01/15 | 2,628 | 2,708 | 2,626 | 2,708 | +104 | +4% | 2,176,400 |
2013/01/11 | 2,590 | 2,609 | 2,577 | 2,604 | +31 | +1.2% | 1,147,200 |
2013/01/10 | 2,534 | 2,575 | 2,534 | 2,573 | +31 | +1.2% | 1,572,200 |
2013/01/09 | 2,520 | 2,550 | 2,517 | 2,542 | +23 | +0.9% | 2,365,400 |
2013/01/08 | 2,490 | 2,519 | 2,478 | 2,519 | +37 | +1.5% | 2,857,700 |
2013/01/07 | 2,478 | 2,500 | 2,475 | 2,482 | +4 | +0.2% | 1,229,900 |
2013/01/04 | 2,455 | 2,478 | 2,454 | 2,478 | +44 | +1.8% | 1,719,200 |
2012/12/28 | 2,445 | 2,449 | 2,426 | 2,434 | ±0 | ±0% | 919,300 |
2012/12/27 | 2,423 | 2,446 | 2,421 | 2,434 | +20 | +0.8% | 1,286,000 |
2012/12/26 | 2,430 | 2,432 | 2,407 | 2,414 | -5 | -0.2% | 747,100 |
2012/12/25 | 2,449 | 2,449 | 2,419 | 2,419 | -14 | -0.6% | 812,400 |
2012/12/21 | 2,449 | 2,450 | 2,426 | 2,433 | -12 | -0.5% | 1,327,000 |
2012/12/20 | 2,433 | 2,455 | 2,432 | 2,445 | +16 | +0.7% | 1,632,900 |
2012/12/19 | 2,428 | 2,439 | 2,420 | 2,429 | +1 | ±0% | 1,501,300 |
2012/12/18 | 2,417 | 2,439 | 2,417 | 2,428 | +11 | +0.5% | 1,526,200 |
2012/12/17 | 2,433 | 2,433 | 2,407 | 2,417 | -5 | -0.2% | 1,478,700 |
2012/12/14 | 2,416 | 2,445 | 2,416 | 2,422 | -8 | -0.3% | 1,725,000 |
2012/12/13 | 2,453 | 2,453 | 2,420 | 2,430 | -19 | -0.8% | 1,107,100 |
2012/12/12 | 2,465 | 2,470 | 2,436 | 2,449 | +3 | +0.1% | 1,545,500 |
2012/12/11 | 2,457 | 2,458 | 2,428 | 2,446 | +18 | +0.7% | 1,370,500 |
2012/12/10 | 2,459 | 2,459 | 2,425 | 2,428 | -1 | ±0% | 1,703,100 |
3051~
3100
件表示中 / 3590件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 792,400円 | +2.2% | +28.0% | 1.77% | 12.68倍 | 1.54倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 378,200円 | +6.0% | +4.0% | 2.06% | 23.34倍 | 4.31倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 448,600円 | -1.1% | +75.3% | 4.46% | 31.07倍 | 1.02倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 168,400円 | +0.9% | +380.2% | 4.63% | 23.20倍 | 1.99倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 264,000円 | +20.9% | +10.6% | 2.50% | 12.48倍 | 1.65倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム